Save the date !

29/05/2021

ESA 2021, Munich

04/08/2021

17th World Congress of Anesthesiologists in Prague, Czech Republic

09/10/2021

ASA San Diego, CA

Machine learning based method for the evaluation of the Analgesia Nociception Index

A research was conducted on the analysis of the information provided by ANI as a valuable tool to replicate the actions of the anesthesiologist in remifentanil analgesia. The results of this research evidenced that including information about the minimum values of ANI together with the hemodynamic information outperformed the decisions made regarding only non-specific traditional signs… View Article
Read more

ANI in 100 peer-reviewed publications

The ANI technology has been validated in more than 100 peer-reviewed publications and has had numerous recommendations with information collected through scientific societies. However, who really validates the index daily are the thousands of doctors that use ANI to guide their analgesics. We would like to generously thank them for their support.      
Read more

How is the ANI value obtianed?

The phenomenon of respiratory sinus arrhythmia causes a difference in milliseconds between consecutive R waves of the ECG. These time variations are plotted obtaining a tachogram, which is then analysed through the spectral analysis of fast wavelet transformation. This allows filtration of the high frequencies (HF) of the tachogram, related only to parasympathetic activity, which… View Article
Read more

New veterinary manual by Dr. Ignacio Sández

Congratulations to Dr. Ignacio Sández Cordero for the completion of his new book “Manual clínico de monitorización anestésica en pequeños animals”, a new veterinary manual in both Spanish and English that details the monitoring in small animals during anesthesia. The book also discusses measuring nociception in pets with MDoloris PTA (Parasympathetic Tone Activity) technology and its effects in… View Article
Read more

Subscribe to our newsletter

Make sure to keep up with the latest news and subscribe to our newsletters